PARP11 inhibitors: PARP11 is one of the most innovative regulators of the evasion of antitumor immunity and resistance to therapies in solid tumors, playing key roles in the immunosuppressive tumor microenvironment (TME) [87]. The gene discussed is PARP11; the disease is neoplasm.